Addus HomeCare (NASDAQ:ADUS) Stock Rating Lowered by Barclays

Addus HomeCare (NASDAQ:ADUS) was downgraded by Barclays from an “equal weight” rating to an “underweight” rating in a research report issued on Tuesday, Marketbeat.com reports. They presently have a $83.00 price target on the stock. Barclays‘s target price suggests a potential downside of 13.09% from the company’s current price.

A number of other research firms have also recently issued reports on ADUS. William Blair reaffirmed an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a report on Thursday, February 29th. Finally, Oppenheimer reiterated an “outperform” rating and issued a $118.00 price objective on shares of Addus HomeCare in a research note on Tuesday, March 26th. One investment analyst has rated the stock with a sell rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus target price of $103.00.

Addus HomeCare Trading Up 0.8 %

NASDAQ:ADUS opened at $95.50 on Tuesday. Addus HomeCare has a 52 week low of $77.30 and a 52 week high of $114.97. The firm has a 50 day moving average of $97.66 and a 200 day moving average of $91.56. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $1.55 billion, a price-to-earnings ratio of 24.87, a PEG ratio of 1.84 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, February 26th. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.17. The business had revenue of $276.35 million during the quarter, compared to analysts’ expectations of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. As a group, sell-side analysts anticipate that Addus HomeCare will post 4.38 earnings per share for the current fiscal year.

Institutional Trading of Addus HomeCare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Principal Securities Inc. acquired a new stake in Addus HomeCare during the fourth quarter valued at $26,000. BluePath Capital Management LLC acquired a new stake in Addus HomeCare during the third quarter valued at $31,000. GAMMA Investing LLC acquired a new stake in Addus HomeCare during the fourth quarter valued at $34,000. Assetmark Inc. grew its position in Addus HomeCare by 17.1% during the third quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock valued at $113,000 after buying an additional 194 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new stake in Addus HomeCare during the third quarter valued at $189,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.